LifeTech Scientific Corporation

HK$1.66As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1302Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (1.02%)
Div yield —
ROE 0.64%
Medical Devices
Beta (5Y) 0.41
PE TTM 118.3
TSR TTM (17.41%)
Mkt cap HK$7.689B
ROIC 2.04%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.98
19.47%
(63.23%)
Hold 6|5|3|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
11.75%
6.97%
18.37%
7.89%
Revenue¥M
383.1
387.4
402.2
390.6
15.08%
10.46%
8.42%
7.88%
Peers (US$980.7M)
Cap (US$)
PE
872.3M
9.981x
654.9M
12.11x
979.2M
—
Capital
TTM
5Y
10Y
Leveragex
1.065
0.080
0.074
EBIT/Intx
2.551
0.356
0.298
Own earn%
(22.86)
(135.95)
(110.36)
Sh yield%
17.49
23.72
24.86
Owners
Insiders/Inst%
9.20
52.22
Short interest%
3.66
SBC / revenue%
5.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
27–31
$1 testx
—
Incr. ROIC%
0